DMK
APGN

David M. Knott’s Apexigen, Inc. Common Stock APGN Stock Holding History

David M. Knott’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$40K Hold
4,000
– – 0.01% 133
2021
Q2 		$40K Hold
4,000
– – 0.01% 129
2021
Q1 		$39K Buy
+4,000
New +$40K 0.02% 116

Other funds holding APGN

Periscope Capital
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

David M. Knott's APGN Position: Q3 2021 in Review

David M. Knott held its Apexigen, Inc. Common Stock (APGN) position steady in Q3 2021 at 4,000 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #133.

David M. Knott first reported a position in APGN in Q1 2021 and has held it in 3 quarters since. 31 funds tracked by Wall St. Rank hold APGN as of Q3 2021.

  • David M. Knott held 4,000 shares of Apexigen, Inc. Common Stock worth $40K as of Q3 2021.
  • David M. Knott left its Apexigen, Inc. Common Stock share count unchanged in Q3 2021.
  • Apexigen, Inc. Common Stock made up 0.01% of David M. Knott's portfolio in Q3 2021, its #133 holding.
  • David M. Knott first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and has held it in 3 quarters since.
  • 31 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.